Viral, Parasitic, Bacterial, and Fungal Infections
Antimicrobial, Host Defense, and Therapeutic Strategies
- 1st Edition - October 15, 2022
- Imprint: Academic Press
- Editors: Debasis Bagchi, Amitava Das, Bernard William Downs
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 8 5 7 3 0 - 7
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 9 8 0 0 - 3
Viral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic Strategies highlight diverse types of infections, including viral, bacterial… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteViral, Parasitic, Bacterial, and Fungal Infections: Antimicrobial, Host Defense, and Therapeutic Strategies highlight diverse types of infections, including viral, bacterial, parasitic, fungal, and the therapeutic efficacy of antibiotics, antivirals, antifungals and other medications, nutraceuticals, and phytotherapeutics. This book addresses the molecular, pathophysiological, and cellular pathways involved in the process of infection. It also examines the host defense mechanisms modulated by innate and adaptive immunity. The book starts off with an introduction, which includes etiology, pathophysiology, and diagnosis of infections. It then goes on to cover a wide spectrum of salient features involved in viral, bacterial, parasitic, and fungal infections and effective therapeutic strategies. In addition, there is a complete section of eight chapters elaborating the detailed aspects of COVID-19 infections, Mucormycosis, Omicron, and strategic vaccines and therapeutics. The book further goes on to discuss novel antibiotics, vaccines, bromhexine, boron compounds, phytotherapeutics, and aspects on boosting immune competence. Contributed by experts in the fields of viral, parasitic, bacterial, and fungal infections, the book comprehensively details the various types of infections such as herpes and COVID-19, their molecular mechanisms, and treatment strategies for those engaged in the research of infectious diseases.
- Details the pathophysiology of various classes of infections
- Examines mechanisms of pathogenesis, immunity, and therapeutics in bacterial, viral, and eukaryotic infectious diseases
- Discusses various aspects on herpes, COVID-19 infections, Mucormycosis, Omicron, vaccines, and therapeutics
- Covers the salient features on zoonosis, prion disease, and diabetic foot infections
- Provides therapeutic strategies of using new antibiotics, vaccines, bromhexine, boron compounds, structurally diverse phytotherapeutics, immune enhancers, and other modalities for treating infections
Virologists, parasitologists, microbiologists, immunologists, public health personnel, infectious diseases physicians, researchers working in the area of infectious diseases. Graduate and medical students working in the area of infectious diseases, Pharmaceutical R&Ds
INTRODUCTION
1. Infections: Definitions, classification and etiology
2. Pathophysiology of Infections
3. Diagnosis of Infection
4. Non-Coding RNA: An Overview
BACTERIAL INFECTIONS AND THERAPEUTICS
5. Bacterial infection and their treatment
6. Novel strategies of combating bacterial infection
7. Role of miRNA in bacterial infection
8. AMPs and host defense against bacterial infection
9. Role of nutrients in combating infection
VIRAL INFECTIONS AND THERAPEUTICS
10. Viral Infection and its management
11. Novel strategies to eliminate viral infections
12. The menace of HIV infection
13. Unmasking an Idiopathic Nemesis: The Herpes Virus
14. Zika Virus infections
15. Ebola Virus: Pathogenesis and Treatment
16. Pathophysiology, Detection and Treatment of CoronaVirus
17. Pandemic of Covid-19
FUNGAL INFECTIONS AND THERAPEUTICS
18. Fungal infections: An unrecognized threat
19. Combinatorial strategies for combating fungal infections
20. Sepsis: Prolific Hypoxia-induced Incubation of Anaerobic Organisms
21. Biofilm infection
PARASITIC INFECTIONS AND THERAPEUTICS
22. Parasitic infection
23. Leishmaniasis and its treatment
24. Malaria: Diagnosis, treatment and control
25. Neglected Parasitic Infections
26. Prion diseases
OTHER INFECTIONS AND THERAPEUTICS
27. Development of point-of-care for bacterial infections
28. Surgical Infections
- Edition: 1
- Published: October 15, 2022
- No. of pages (Paperback): 978
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780323857307
- eBook ISBN: 9780323898003
DB
Debasis Bagchi
Debasis Bagchi, PhD, MACN, CNS, MAIChE, received his Ph.D. in Medicinal Chemistry in 1982. He is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX, and Chief Scientific Officer at Cepham Research Center, Piscataway, NJ, Adjunct Faculty in Texas Southern University, Houston, TX. He served as the Senior Vice President of Research & Development of InterHealth Nutraceuticals Inc, Benicia, CA, from 1998 until Feb 2011, and then as Director of Innovation and Clinical Affairs, of Iovate Health Sciences, Oakville, ON, until June 2013. Dr. Bagchi received the Master of American College of Nutrition Award in October 2010. He is the Past Chairman of International Society of Nutraceuticals and Functional Foods (ISNFF), Past President of American College of Nutrition, Clearwater, FL, and Past Chair of the Nutraceuticals and Functional Foods Division of Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor on the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a Member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD. He has published 321 papers in peer reviewed journals, 30 books, and 18 patents. Dr. Bagchi is also a Member of the Society of Toxicology, Member of the New York Academy of Sciences, Fellow of the Nutrition Research Academy, and Member of the TCE stakeholder Committee of the Wright Patterson Air Force Base, OH. He is also Associate Editor for the Journal of Functional Foods, Journal of the American College of Nutrition, and the Archives of Medical and Biomedical Research, and is also serving as Editorial Board Member of numerous peer reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Toxicology Mechanisms and Methods, and The Original Internist, among others.
Affiliations and expertise
Professor, Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, USA; Chief Scientific Officer, Cepham Research Center, Piscataway, New Jersey; Adjunct Faculty, Texas Southern University, Houston, Texas, USAAD
Amitava Das
Amitava Das, PhD, is a Postdoctoral Researcher at Indiana Center for Regenerative Medicine and Engineering (ICRME), Indiana University School of Medicine. Dr. Das earned his Bachelor’s and Master’s in Pharmacy and Pharmaceutical Chemistry, respectively, from PES College of Pharmacy, Bangalore, India. He earned his PhD degree in Human Nutrition from The Ohio State University in 2016 after which he joined as a Postdoctoral Researcher in Department of Surgery at The Ohio State University Medical Center, and then moved to Indiana University in 2018. His research interests are tissue repair and regeneration in diabetes and Nutraceuticals. He has published over 20 research papers and numerous book chapters. Since 2017, Dr. Das is a member of the Editorial Board of Journal of American College of Nutrition and a Communications committee member of the Wound Healing Society. Dr. Das also serves as a reviewer for multiple prestigious journals. He has presented at various national and international conferences and is the recipient of several awards.
Affiliations and expertise
Postdoctoral Researcher, Indiana Center for Regenerative Medicine and Engineering (ICRME), Indiana University School of Medicine, Indianapolis, Indiana, USABD
Bernard William Downs
Bernard William (Bill) Downs received his Bachelor of Science degree in 1975 from Pennsylvania State University. Downs simultaneously pursued his master’s degree and Ph.D. in Nutrition and Biochemistry at Immaculata University in Immaculata, PA; advanced degree not completed. He became Director of Therapeutic Nutrition for Morrison Family and Sports Medicine, Huntingdon Valley, PA from 1990 till 1996. Downs served as the Director of Technical Sales for InterHealth Nutraceuticals Inc., Benicia, CA from 1990 till 2003. He was the Director of Research and Development for Allied Nutraceutical Research, Blue Bell, PA, from 2003 till 2008. Downs served as the CEO of LifeGen Research from 2009 till 2013, Lederach, PA. Downs is Founder and CEO of Victory Nutrition International, Inc., a Research & Development Biotech Company, Lederach, PA. Downs is a member of the American Association for the Advancement of Science, the American College of Nutrition, and past member of the NY Academy of Sciences. He is on the editorial review board of the Journal of Reward Deficiency Syndrome. Downs has authored or co-authored 105 papers published in peer-reviewed journals, numerous chapters in texts and handbooks for clinicians and researchers, with patents-pending in nutraceutical biotechnology. Research publications have been on issues ranging from immunity, anemia and metabolic disorders to addictions, obsessions, compulsions, and personality disorders, among other Reward Deficiency Syndrome conditions.
Affiliations and expertise
Founder, Victory Nutrition International, Inc., Lederach, Pennsylvania; CEO,Victory Nutrition International, Inc., Lederach, Pennsylvania, USARead Viral, Parasitic, Bacterial, and Fungal Infections on ScienceDirect